Optinose to Announce Q3 2024 Financial Results with Investor Call

Optinose

YARDLEY, PA — Optinose (NASDAQ: OPTN) is set to disclose its financial results for the third quarter of 2024, along with key corporate updates, on Tuesday, November 12, 2024, before the market opens. This announcement will provide investors and stakeholders with insights into the company’s recent performance and strategic direction.

Following the release, Optinose’s leadership team will host a conference call to discuss the detailed financial results and corporate developments. The call is scheduled to begin at 8:00 a.m. Eastern Time on the same day. Interested participants can access the live webcast by visiting the Investors section of Optinose’s official website.

For those preferring to join via telephone, prior registration is required. Upon registering, participants will receive a confirmation email containing the necessary dial-in details and a personal PIN for call access. Additionally, a replay of the webcast will be available on the company’s website for a duration of 60 days following the event, ensuring ample time for interested parties to review the discussion.

This upcoming announcement marks an important opportunity for Optinose to communicate its financial health and future plans to its investors and the general public.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.

READ:  Windtree Therapeutics Highlights Istaroxime’s Promise for Cardiogenic Shock